CIRS Membership

Membership to the CIRS Regulatory and Access programme is open to all pharmaceutical companies, particularly those engaged in research and development of new active substances, prescription medicines, devices and biologics with a view to global product development, regulatory affairs and market access.

By becoming a member, your company can support CIRS’ mission to advance regulatory and HTA policies and processes; participate in multi-stakeholder activities such as workshops, research and benchmarking metrics projects; benefit from priority access to CIRS publications; and become part of an international community to help shape major policy topics.

If your company would like to find out more about becoming a CIRS member, please download our brochure, or alternatively contact Gill Hepton: